{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T20:10:27Z","timestamp":1732651827394,"version":"3.28.2"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150338","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T23:53:21Z","timestamp":1721778801000},"page":"150338","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma"],"prefix":"10.1016","volume":"734","author":[{"given":"Yufu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaozhuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiqiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbrc.2024.150338_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2024.150338_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semcancer.2019.08.024","article-title":"The adjuvant treatment revolution for high-risk melanoma patients","volume":"59","author":"Spagnolo","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150338_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150338_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bbrc.2024.150338_bib5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma","volume":"24","author":"Gide","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150338_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101753","article-title":"Adaptive redox homeostasis in cutaneous melanoma","volume":"37","author":"Arslanbaeva","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150338_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/DAD.0000000000001453","article-title":"Morphologic forms and classification of dermal mitotic figure density in primary cutaneous melanoma: a retrospective study","volume":"42","author":"Marsch","year":"2020","journal-title":"Am. J. Dermatopathol."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150338_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbrc.2024.150338_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: from mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2024.150338_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/TACG.S69210","article-title":"The genetics of uveal melanoma: current insights","volume":"9","author":"Hoiom","year":"2016","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.bbrc.2024.150338_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.570654","article-title":"Prognostic role of tumor mutation burden combined with immune infiltrates in skin cutaneous melanoma based on multi-omics analysis","volume":"10","author":"Yan","year":"2020","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.bbrc.2024.150338_bib12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Michael","year":"2014","journal-title":"Genome Biol."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150338_bib13","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Matthew","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.bbrc.2024.150338_bib14","article-title":"Integrated analysis of lncRNA-mediated ceRNA network in lung adenocarcinoma","volume":"15","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150338_bib15","article-title":"ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150338_bib16","article-title":"Applying logistic LASSO regression for the diagnosis of atypical Crohn's disease","volume":"12","author":"Ying","year":"2022","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.bbrc.2024.150338_bib17","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Gregor","year":"2019","journal-title":"Bioinformatics"},{"issue":"17","key":"10.1016\/j.bbrc.2024.150338_bib18","article-title":"The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations","volume":"42","author":"Yuanbin","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bbrc.2024.150338_bib19","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Janet","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150338_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","article-title":"Malignant melanoma: skin cancer-diagnosis, prevention, and treatment","volume":"30","author":"Ahmed","year":"2020","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150338_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CMR.0000000000000082","article-title":"Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features","volume":"24","author":"Gru","year":"2014","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150338_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13045-021-01213-z","article-title":"Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019","volume":"14","author":"Lin","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150338_bib23a","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.32764","article-title":"Burden of melanoma in China,1990-2017: findings from the 2017 global burden of disease study","volume":"147","author":"Wu","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"10151","key":"10.1016\/j.bbrc.2024.150338_bib23b","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bbrc.2024.150338_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1046\/j.1523-1747.2000.00958.x","article-title":"Expression of CD94\/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma","volume":"114","author":"Vetter","year":"2000","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.bbrc.2024.150338_bib25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","article-title":"Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma","volume":"24","author":"Auslander","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.150338_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/gene.2014.59","article-title":"Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"16","author":"Buttini","year":"2015","journal-title":"Gene Immun."},{"issue":"9","key":"10.1016\/j.bbrc.2024.150338_bib27","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1177\/1352458520963937","article-title":"PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity","volume":"27","author":"Sidore","year":"2021","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150338_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5114\/ceji.2014.42135","article-title":"Perforin: an important player in immune response","volume":"39","author":"Osi\u0144ska","year":"2014","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.bbrc.2024.150338_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.0b013e318245d250","article-title":"CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Schneider-Hohendorf","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.bbrc.2024.150338_bib30","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ejhg.2013.20","article-title":"Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation","volume":"21","author":"Dias","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150338_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fgene.2020.00126","article-title":"Neurologic manifestations as initial clinical presentation of familial hemophagocytic lymphohistiocytosis type2 due to PRF1 mutation in Chinese pediatric patients","volume":"11","author":"Feng","year":"2020","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150338_bib32","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057848","article-title":"Primary hemophagocytic lymphohistiocytosis with prolonged primary neurologic presentation","volume":"151","author":"Gupta","year":"2023","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.bbrc.2024.150338_bib33","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1177\/1352458520963937","article-title":"PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity","volume":"27","author":"Sidore","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbrc.2024.150338_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1306338","article-title":"Case Report: chronic inflammatory demyelinating polyradiculoneuropathy rather than hemophagocytic lymphohistiocytosis-the initial phenotype of PRF1 gene mutation","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2024.150338_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.646252","article-title":"CXCL11 correlates with antitumor immunity and an improved prognosis in colon cancer","volume":"9","author":"Cao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150338_bib36","first-page":"820","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancerNat","volume":"27","author":"Bassez","year":"2021","journal-title":"M\u00e9d."},{"issue":"10","key":"10.1016\/j.bbrc.2024.150338_bib37","first-page":"2330","article-title":"Single-cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic CancerCancer discov","volume":"12","author":"Schalck","year":"2022"},{"issue":"4","key":"10.1016\/j.bbrc.2024.150338_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101042","article-title":"PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma","volume":"14","author":"Fan","year":"2021","journal-title":"Transl Oncol"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2400874X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2400874X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T19:31:13Z","timestamp":1732649473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2400874X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":39,"alternative-id":["S0006291X2400874X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150338","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150338"}}